Moving from basic toward systems pharmacodynamic models.
about
Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology ModelsQuantitative and logic modelling of molecular and gene networksMeta-modeling of methylprednisolone effects on glucose regulation in ratsMedication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.Systems approach to the study of brain damage in the very preterm newborn.Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells.Parsing interindividual drug variability: an emerging role for systems pharmacology.A model qualification method for mechanistic physiological QSP models to support model-informed drug development.Quantitative Systems Pharmacology: A Framework for Context.From an indirect response pharmacodynamic model towards a secondary signal model of dose-response relationship between exercise training and physical performanceUnderstanding Physiology in the Continuum: Integration of Information from Multiple -Omics Levels.Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformations.Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology.Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia
P2860
Q26779458-5D234E32-F5A9-48A5-8D16-A7300D5DEF1AQ28083248-B91BBADF-A0EC-4A4E-A734-9AC165B9D631Q28535673-57A33715-66A1-4F05-8E9A-FBCF4667B590Q30248258-C23E6074-87AF-49B6-BAF9-FFCDC45DE63CQ35407486-38CE2012-DBE8-4A7C-AAFC-579E59C63CBBQ35962054-6F317DC2-802B-4A58-BC1F-467789B73D96Q36417380-5C8C6070-6125-45C8-BD59-C8105C62D466Q36600060-14BC76AA-1FA5-4F85-A127-A249C3ACA938Q37200950-D727CD8C-7A4C-4356-A364-08FC45DEBDF6Q37578864-4D58150E-81BD-43F6-8A3B-DF884A9396B9Q37668704-6BB158BC-11D4-4DCB-B2CB-4317C27D64BDQ38587550-F583F51A-E0BB-42C0-9425-3568592EF727Q38896504-EE1E3FD1-0033-4171-9A30-AA1B6F9713E4Q40905288-6F3A29A6-01F3-4610-8A22-82E914E5D8EBQ41494950-586F4C71-5867-4CC4-A453-692E2DA03549Q49894254-3812D610-F4A3-443A-AEDD-F9C8261A7F49Q50524228-BA518AF4-7622-4B5C-B826-8A821CD5FF79Q55032467-7F88E13F-B047-4173-AC76-3EF1C5F7F352Q58705274-3C0DCBF8-8597-4FAD-87A2-F341AC721B31
P2860
Moving from basic toward systems pharmacodynamic models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Moving from basic toward systems pharmacodynamic models.
@en
Moving from basic toward systems pharmacodynamic models.
@nl
type
label
Moving from basic toward systems pharmacodynamic models.
@en
Moving from basic toward systems pharmacodynamic models.
@nl
prefLabel
Moving from basic toward systems pharmacodynamic models.
@en
Moving from basic toward systems pharmacodynamic models.
@nl
P2860
P356
P1476
Moving from basic toward systems pharmacodynamic models.
@en
P2093
William J Jusko
P2860
P304
P356
10.1002/JPS.23590
P407
P577
2013-05-16T00:00:00Z